FindTrial
Sign In

Development of diagnostic method for colon cancer using mutational analyses of tumor tissues and plasma

Development of diagnostic method for colon cancer using mutational analyses of tumor tissues and plasma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008037
Enrollment
350
Registered
2022-12-23
Start date
2017-08-23
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

EONE-DIAGNOMICS GENOME CENTER
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years or older (male and female) diagnosed with colorectal cancer 2. Patients whose residual tumor is confirmed to be larger than 1cm in diameter after the removed tumor is used for diagnostic purposes 3. When both cancer tissue and plasma can be collected 4. Sign the consent form 5. Patients who are willing to perform all trial-related procedures within the clinical trial period

Exclusion criteria

Exclusion criteria: 1. If only biopsy is performed 2. In case of accompanying other carcinoma 3. If the patient does not consent

Design outcomes

Primary

MeasureTime frame
ctDNA Efficiency Assessment, Checking the type and frequency of mutations—

Countries

Korea, Republic of

Contacts

Public ContactChang-Hyeok An

The Catholic University of Korea, Bucheon St. Mary's Hospital

achcolo@catholic.ac.kr+82-32-340-7028

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 10, 2026